Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oncopeptides AB | 390,303 | net | 17 Mar 2026 | tx 11+390,303 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Mar 2026 | PURCHASE | Oncopeptides AB | 87,833 | 1.55 SEK | |
| 15 Sept 2025 | PURCHASE | Oncopeptides AB | 12,626 | 3.20 SEK | |
| 15 Sept 2025 | PURCHASE | Oncopeptides AB | 19,312 | 3.20 SEK | |
| 26 Aug 2025 | PURCHASE | Oncopeptides AB | 56,820 | 4.40 SEK | first after silence |
| 03 May 2024 | PURCHASE | Oncopeptides AB | 66,804 | 2.60 SEK | |
| 25 Apr 2024 | PURCHASE | Oncopeptides AB | 30,000 | 0.14 SEK | derivfirst after silence |
| 01 Dec 2021 | PURCHASE | Oncopeptides AB | 529 | 10.03 SEK | |
| 02 Dec 2021 | PURCHASE | Oncopeptides AB | 68 | 9.98 SEK | |
| 02 Dec 2021 | PURCHASE | Oncopeptides AB | 19,507 | 9.95 SEK |
2 purchases reported after at least 12 months of silence — most recent on 26 Aug 2025.